Dr. Lal Path Labs Ltd. — Updates, 31-10-2025: Press Release
31-10-2025 | 02:35 pm
31-10-2025 | 02:35 pm
Dr Lal PathLabs reported Q2 FY26 revenue of Rs 731 Cr (+10.7%), with EBITDA up 10.8% and PAT up 16.4%. The Board approved a 1:1 bonus share issue and declared an interim dividend of Rs 7 per share.
No comments yet. Be the first to comment!
